Related Experiment Video
Updated: May 20, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
Evaluation of fibronectin and C-reactive protein levels in patients with sepsis: a case-control study
Mojgan Mamani1, Seyyed Hamid Hashemi, Mehrdad Hajilooi
1Department of Infectious Diseases, Hamedan University of Medical Sciences, Hamedan, Iran.
Insights
Sepsis diagnosis can be improved by measuring plasma levels of fibronectin and C-reactive protein (CRP). Elevated CRP and decreased fibronectin show potential as reliable sepsis biomarkers.
Area of Science:
- Biochemistry
- Clinical Medicine
- Infectious Diseases
Background:
- Sepsis affects 750,000 Americans annually and is a leading cause of death.
- Improved diagnosis and management of sepsis are urgently needed.
- Current diagnostic methods require enhancement for timely intervention.
Purpose of the Study:
- To evaluate plasma levels of fibronectin and C-reactive protein (CRP) in sepsis patients.
- To compare these levels with patients having other infectious diseases without sepsis.
- To identify potential biomarkers for sepsis diagnosis.
Main Methods:
- A case-control study involving 90 sepsis patients and 90 non-septic infectious disease patients.
- Measurement of serum fibronectin and CRP levels.
- Statistical analysis using SPSS version 15.
Main Results:
- Mean fibronectin levels were lower in sepsis patients (288.97±89.10 mg/l) compared to controls (341.24±110.53 mg/l), P=0.001.
- Mean CRP levels were significantly higher in sepsis patients (89.42±54.05 µg/ml) versus controls (27.42±25.89 µg/ml), P<0.001.
- Elevated CRP was noted in septic patients with urinary tract infection, pneumonia, and soft tissue infections.
Conclusions:
- Decreased fibronectin and increased CRP plasma levels may serve as reliable diagnostic markers for sepsis.
- C-reactive protein (CRP) shows potential as a superior predictive factor for sepsis compared to fibronectin.
- Further research can validate these findings for clinical application.
Abstract:
Sepsis is a significant health problem with an estimated 750,000 new cases in the USA annually. It is also the third leading cause of death in developed countries, equaling the number of fatalities from acute myocardial infarction. The high sepsis-related mortalities mean there is an urgent need to improve the diagnosis and management of sepsis patients. The aim of this study was the evaluation of fibronectin and C-reactive protein (CRP) plasma levels in patients with sepsis and other infectious diseases without sepsis. In a case-control study, 90 patients with sepsis and 90 patients with other infectious diseases without sepsis were studied. Serum levels of fibronectin and CRP were measured. The data were analyzed by SPSS version 15. The mean levels of fibronectin in the cases and controls were 288.97±89.10 mg/l and 341.24±110.53 mg/l respectively (P=0.001). The mean levels of CRP in the cases and controls were 89.42±54.05 µg/ml and 27.42±25.89 µg/ml respectively (P<0.001). Concerning the source of infection, the mean CRP levels were significantly higher in septic patients with urinary tract infection, pneumonia, and soft tissue infection (P<0.001). Decreased levels of fibronectin and increased levels of CRP may be considered as reliable diagnostic markers for sepsis. Also, CRP could be a better predictive factor for sepsis than fibronectin.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pneumonia III: Complications and Assessment
Acute Inflammation III: Local and Systemic Effects
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...